Willi Koch

Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study

C. von Kalle, F. Tacke, Sebastian Albus, 2021, Clinical Microbiology and Infection.

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

N. Suttorp, P. Schommers, L. Sander, 2022, Emerging infectious diseases.

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

C. von Kalle, N. Suttorp, D. Treue, 2021, The Lancet Respiratory Medicine.

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

C. von Kalle, N. Suttorp, V. Corman, 2021, Emerging infectious diseases.

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021

N. Suttorp, V. Corman, C. Drosten, 2021, Emerging infectious diseases.

Reactogenicity of homologous and heterologous prime-boost immunization with BNT162b2 and ChAdOx1-nCoV19: a prospective cohort study

N. Suttorp, D. Treue, V. Corman, 2021, medRxiv.